1st Quarter - Report

WILLIAMS AND JENSEN, PLLC for WYETH (FORMERLY AMERICAN HOME PRODUCTS)

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements indlucing S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Health care reform; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

LobbyistCovered position, as disclosed
REBECCA ANDERSON White House Office of Legislative Affairs
BERTRAM CARP —
JENNY DIJAMES LA and LD, Rep. Bud Cramer
JACK STEVEN HART —
SUSAN HIRSCHMANN COS, Rep.Van Hilleary & Majority Whip
KARINA LYNCH Staff, Sen. Spcl. Cmtee on Aging and Gov. Affrs.
JOHN J MCMACKIN —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 369 (111th), H.R. 1427 (111th), S. 301 (111th), H.R. 1706 (111th), S. 726 (111th), H.R. 1 (111th), H.R. 573 (111th), S. 525 (111th), S. 501 (111th), S. 357 (111th), H.R. 579 (111th), H.R. 1298 (111th), H.R. 1548 (111th)

Medicare/Medicaid MMM

Medicaid drug rebates including S. 547/H.R. 904, Drug Rebate Equalization Act of 2009; H.R. 1725, Voluntary State Discount Prescription Drug Plan Act of 2009 and Medicare drug price negotiation, payment, and coverage including S. 330/H.R. 684, Medicare Prescription Drug Savings and Choice Act of 2009; S. 266, Medicare Prescription Drug Gap Reducation Act of 2009.

LobbyistCovered position, as disclosed
JENNY DIJAMES LA and LD, Rep. Bud Cramer
JACK STEVEN HART —
KARINA LYNCH Staff, Sen. Spcl. Cmtee on Aging and Gov. Affrs.
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 330 (111th), S. 266 (111th), H.R. 1725 (111th), H.R. 904 (111th), S. 547 (111th), H.R. 684 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.